firstminute capital, together with btov, the think-cell founders and other business angels, has invested EUR 3.8 million in the health-tech start-up Vantis.
The Osborne Clarke team consisted of Maximilian Vocke (lead) and Dana Alpar (both corporate / VC, Berlin (Germany)).
Vantis is a Munich-based start-up founded in 2019 that develops digital solutions for cardiovascular diseases. Their first product is a digital therapy program for coronary heart disease and will be available to the German market in summer 2021. The investment will be used to launch the product and further build up the team.
On the background of the product, Vantis combines an app intervention with sensor technology and virtual care to provide continuous treatment for patients with chronic cardiovascular disease. The product includes a personalized lifestyle adjustment program, medication therapy support, monitoring of key vital signs via an integrated blood pressure and pulse monitor, and assistance with symptom assessment and linkage to the treating physician.
Our client, firstminute capital, is a global VC fund founded in 2017, headquartered in London and further based in Berlin. The fund manages assets of USD 240 million, with a focus on early-stage tech startups. It counts 100 Unicorn founders among its investors, including the founders of Zalando, Palantir, Supercell, Wayfair, MongoDB, Adyen, Xing, and King.